Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$1.14 - $3.48 $71,535 - $218,370
-62,750 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$3.07 - $5.55 $16,578 - $29,970
5,400 Added 9.42%
62,750 $207,000
Q4 2021

Feb 14, 2022

BUY
$5.12 - $14.5 $293,632 - $831,575
57,350 New
57,350 $298,000
Q3 2021

Nov 15, 2021

SELL
$12.9 - $16.83 $231,103 - $301,509
-17,915 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$13.28 - $18.45 $77,953 - $108,301
-5,870 Reduced 24.68%
17,915 $304,000
Q1 2021

May 17, 2021

BUY
$11.23 - $18.35 $267,105 - $436,454
23,785 New
23,785 $428,000

About HELIUS MEDICAL TECHNOLOGIES, INC.


  • Ticker HSDT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,197,200
  • Market Cap $20.3M
  • Description
  • Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gai...
More about HSDT
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.